Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2003 1
2004 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Effect of polyoxidonium on the phagocytic activity of human peripheral blood leukocytes.
Dambaeva SV, Mazurov DV, Golubeva NM, D'yakonova VA, Pinegin BV, Khaitov RM. Dambaeva SV, et al. Russ J Immunol. 2003 Apr;8(1):53-60. Russ J Immunol. 2003. PMID: 12717555
The effect of polyoxidonium on the functional activity of human peripheral blood phagocytes was studied in vitro. ...Polyoxidonium proved to have an antioxidant activity at all doses tested (100, 250, and 500 &mgr …
The effect of polyoxidonium on the functional activity of human peripheral blood phagocytes
Study of interaction between the polyoxidonium immunomodulator and the human immune system cells.
Dyakonova VA, Dambaeva SV, Pinegin BV, Khaitov RM. Dyakonova VA, et al. Int Immunopharmacol. 2004 Dec 15;4(13):1615-23. doi: 10.1016/j.intimp.2004.07.015. Int Immunopharmacol. 2004. PMID: 15454114
Polyoxidonium (PO) is a high-molecular weight physiologically active compound with pronounced immunomodulating activity, an N-oxidized polyethylene-piperazine derivative. ...A dose-dependent increase in the intracellular killing by blood phagocytes
Polyoxidonium (PO) is a high-molecular weight physiologically active compound with pronounced immunomodulating activity
[Clinical trial of domestic drug polyoxidonium in secondary immunodeficiency].
Borisova AM, Laktionova LV, Setdikova NKh. Borisova AM, et al. Ter Arkh. 1998;70(10):52-7. Ter Arkh. 1998. PMID: 9864806 Clinical Trial. Russian.
MATERIALS AND METHODS: 56 patients entered the trial; 13 with CB in remission, 22 with CB in exacerbation and 21 with chronic recurrent furunculosis. Clinical examinations and tests were made before polyoxidonium therapy and 2-3 days after it. Immunological tests consisted …
MATERIALS AND METHODS: 56 patients entered the trial; 13 with CB in remission, 22 with CB in exacerbation and 21 with chronic recurrent furu …
Feedback